Mirae Asset Global Investments’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Buy |
2,109
+322
| +18% | +$3.66K | ﹤0.01% | 1371 |
|
|
2025
Q1 | $12.9K | Buy |
1,787
+22
| +1% | +$159 | ﹤0.01% | 1444 |
|
|
2024
Q4 | $19.5K | Buy |
+1,765
| New | +$19.5K | ﹤0.01% | 1426 |
|
|
2024
Q2 | – | Sell |
-90,663
| Closed | -$728K | – | 2415 |
|
|
2024
Q1 | $728K | Buy |
+90,663
| New | +$728K | ﹤0.01% | 1708 |
|
|
2023
Q4 | – | Sell |
-146,076
| Closed | -$576K | – | 2596 |
|
|
2023
Q3 | $576K | Buy |
146,076
+12,478
| +9% | +$49.2K | ﹤0.01% | 1811 |
|
|
2023
Q2 | $1.42M | Buy |
133,598
+41,242
| +45% | +$438K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $769K | Buy |
92,356
+741
| +0.8% | +$6.17K | ﹤0.01% | 1679 |
|
|
2022
Q4 | $846K | Sell |
91,615
-2,738
| -3% | -$25.3K | ﹤0.01% | 1584 |
|
|
2022
Q3 | $1.21M | Buy |
94,353
+13,555
| +17% | +$174K | ﹤0.01% | 1383 |
|
|
2022
Q2 | $1.07M | Buy |
+80,798
| New | +$1.07M | ﹤0.01% | 1372 |
|